January 29, 2017
ruxolitinib and pegasys for treating MPNs

Dr Mesa and Dr Mikhael Discuss Latest MPN Research 2017

A Solid Summary on the Latest MPN Research in 2017 Drs. Joseph R. Mikhael and Ruben A. Mesa analyze and discuss pertinent clinical studies and late […]
January 2, 2017

Dying for Answers – Radiation Link to Myeloproliferative Neoplasms

Long Term Exposure to Radiation puts you at higher risk for MPN The Savannah River Site is on a list of qualified places for Special Exposure […]
December 21, 2016
MPN survey ET

Survey Seeking Essential Thrombocythemia Patients to Share Their Experiences

A survey is being conducted to learn more about the most common symptoms experienced by ET patients, and how these symptoms affect the lives of patients.  […]
October 18, 2016

Is a Cure for Blood Cancer Around the Corner?

New Leukemia Research in Phase I/IIa Clinical Trial Biosight, an Israeli pharmaceutical development company that is working on a cure for leukemia, this week closed an […]
September 21, 2016
hearing loss in PV

Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera

[contentcards url=”http://www.oncologynurseadvisor.com/leukemia/factors-associated-with-hearing-loss-in-pv-pinpointed/article/523647/” target=”_blank”] “Researchers found that the mean hemoglobin and hematocrit levels of the polycythemia vera group were 16.7 g/dL and 50.4%, respectively, vs 13.4 g/dL […]
September 20, 2016
ropeginterferon

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Key points The novel IFNα-2b AOP2014 administered once every two weeks (or once a month) has low toxicity and induces high and sustained response rates in […]
MPN Cancer Connection
Malcare WordPress Security